Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maurice Buchbinder

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
JAMA Network Open|October 27, 2022
Long-term Outcomes of Transcatheter Aortic Valve Replacement With the Lotus Valve vs CoreValve/EvolutR: A Secondary Analysis of the REPRISE III Randomized Clinical TrialDavid G Rizik, Vivek Rajagopal, Raj R Makkar, et al.
International Journal of Cardiology|October 13, 2023
Self-expanding and balloon-expandable valves in low risk TAVR patientsSukhdeep Bhogal, Ron Waksman, Corey Shea, et al.
International Journal of Cardiology|October 22, 2022
Subclinical leaflet thrombosis and antithrombotic therapy post-TAVI: An LRT substudySukhdeep Bhogal, Ron Waksman, Paul Gordon, et al.
Journal of the American College of Cardiology|April 19, 2008
A novel bioresorbable polymer paclitaxel-eluting stent for the treatment of single and multivessel coronary disease: primary results of the COSTAR (Cobalt Chromium Stent With Antiproliferative for Restenosis) II studyMitchell W Krucoff, Dean J Kereiakes, John L Petersen, et al.
The American Journal of Cardiology|November 28, 2006
Comparison of the efficacy of direct coronary stenting with sirolimus-eluting stents versus stenting with predilation by intravascular ultrasound imaging (from the DIRECT trial)Atsushi Hirohata, Yoshihiro Morino, Junya Ako, et al.
Circulation. Cardiovascular Interventions|April 22, 2025
Impact of Calcified Raphe on TAVR in Bicuspid Patients: Predicting Redo-TAVR Feasibility and Virtual Planning ImplicationsPavan Reddy, Fernando J Rodriguez-Weisson, Giorgio A Medranda, et al.
JACC. Cardiovascular Interventions|September 2, 2019
Outcomes of Veterans Undergoing TAVR Within Veterans Affairs Medical Centers: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking ProgramPhilip S Hall, Colin I O'Donnell, Verghese Mathew, et al.
Journal of the American College of Cardiology|March 25, 2014
Transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgeryJeffrey J Popma, David H Adams, Michael J Reardon, et al.
American Heart Journal|March 13, 2021
Transcatheter aortic valve replacement in low-risk patients: 2-year results from the LRT trialRon Waksman, Rebecca Torguson, Giorgio A Medranda, et al.
Circulation. Cardiovascular Interventions|May 16, 2023
Transcatheter Aortic Valve Replacement and Impact of Subclinical Leaflet Thrombosis in Low-Risk Patients: LRT Trial 4-Year OutcomesRon Waksman, Sukhdeep Bhogal, Paul Gordon, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
JAMA Network Open|October 27, 2022
Long-term Outcomes of Transcatheter Aortic Valve Replacement With the Lotus Valve vs CoreValve/EvolutR: A Secondary Analysis of the REPRISE III Randomized Clinical TrialDavid G Rizik, Vivek Rajagopal, Raj R Makkar, et al.
International Journal of Cardiology|October 13, 2023
Self-expanding and balloon-expandable valves in low risk TAVR patientsSukhdeep Bhogal, Ron Waksman, Corey Shea, et al.
International Journal of Cardiology|October 22, 2022
Subclinical leaflet thrombosis and antithrombotic therapy post-TAVI: An LRT substudySukhdeep Bhogal, Ron Waksman, Paul Gordon, et al.
Journal of the American College of Cardiology|April 19, 2008
A novel bioresorbable polymer paclitaxel-eluting stent for the treatment of single and multivessel coronary disease: primary results of the COSTAR (Cobalt Chromium Stent With Antiproliferative for Restenosis) II studyMitchell W Krucoff, Dean J Kereiakes, John L Petersen, et al.
The American Journal of Cardiology|November 28, 2006
Comparison of the efficacy of direct coronary stenting with sirolimus-eluting stents versus stenting with predilation by intravascular ultrasound imaging (from the DIRECT trial)Atsushi Hirohata, Yoshihiro Morino, Junya Ako, et al.
Circulation. Cardiovascular Interventions|April 22, 2025
Impact of Calcified Raphe on TAVR in Bicuspid Patients: Predicting Redo-TAVR Feasibility and Virtual Planning ImplicationsPavan Reddy, Fernando J Rodriguez-Weisson, Giorgio A Medranda, et al.
JACC. Cardiovascular Interventions|September 2, 2019
Outcomes of Veterans Undergoing TAVR Within Veterans Affairs Medical Centers: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking ProgramPhilip S Hall, Colin I O'Donnell, Verghese Mathew, et al.
Journal of the American College of Cardiology|March 25, 2014
Transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgeryJeffrey J Popma, David H Adams, Michael J Reardon, et al.
American Heart Journal|March 13, 2021
Transcatheter aortic valve replacement in low-risk patients: 2-year results from the LRT trialRon Waksman, Rebecca Torguson, Giorgio A Medranda, et al.
Circulation. Cardiovascular Interventions|May 16, 2023
Transcatheter Aortic Valve Replacement and Impact of Subclinical Leaflet Thrombosis in Low-Risk Patients: LRT Trial 4-Year OutcomesRon Waksman, Sukhdeep Bhogal, Paul Gordon, et al.
Pageof 6